Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | -4.00% | -15.79% | +108.70% |
23/04 | Pharmaust CEO Resigns | MT |
10/04 | PharmAust Obtains Approval to Commence Monepantel Extension Study | MT |
Sales 2022 | 4.51M 2.95M 246M | Sales 2023 | 3.82M 2.49M 208M | Capitalization | 26.06M 17.02M 1.42B |
---|---|---|---|---|---|
Net income 2022 | -1M -653K -54.46M | Net income 2023 | -6M -3.92M -327M | EV / Sales 2022 | 4.69 x |
Net cash position 2022 | 1.03M 676K 56.36M | Net cash position 2023 | 1.67M 1.09M 91.1M | EV / Sales 2023 | 6.39 x |
P/E ratio 2022 |
-13
x | P/E ratio 2023 |
-3.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.38% |
1 day | -4.00% | ||
1 week | -15.79% | ||
Current month | -36.00% | ||
1 month | -29.41% | ||
3 months | +45.45% | ||
6 months | +238.03% | ||
Current year | +108.70% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Thurn
CEO | Chief Executive Officer | - | 01/23/01 |
Sam Wright
DFI | Director of Finance/CFO | 46 | 01/06/01 |
Roger Aston
CHM | Chairman | 68 | 12/13/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Aston
CHM | Chairman | 68 | 12/13/12 |
Sam Wright
DFI | Director of Finance/CFO | 46 | 01/06/01 |
Neville Bassett
BRD | Director/Board Member | - | 02/18/02 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.24 | -4.00% | 586,133 |
24/24/24 | 0.25 | +6.38% | 1,820,798 |
23/24/23 | 0.235 | -18.97% | 6,945,334 |
22/24/22 | 0.29 | +1.75% | 768,304 |
19/24/19 | 0.285 | -10.94% | 768,513 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+108.70% | 61.83M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PAA Stock